Target Name: MX2
NCBI ID: G4600
Review Report on MX2 Target / Biomarker Content of Review Report on MX2 Target / Biomarker
MX2
Other Name(s): MX dynamin like GTPase 2 | Interferon-induced GTP-binding protein Mx2 | MX2_HUMAN | MXB | Myxovirus resistance protein 2 | myxovirus (influenza virus) resistance 2 | p78-related protein | myxovirus resistance protein 2 | interferon-regulated resistance GTP-binding protein MXB | second interferon-induced protein p78 | Interferon-regulated resistance GTP-binding protein MxB | Second interferon-induced protein p78

MX2: A Potential Drug Target Or Biomarker

MX2, or MX2-like GTPase 2, is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the cell cycle, and is involved in the process of cell division and growth. MX2 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, MX2 has potential as a drug target or biomarker.

The MX2 protein is composed of 219 amino acid residues, and has a calculated molecular weight of 23.9 kDa. It is found in a variety of tissues and cells, including muscle, heart, and brain. MX2 is primarily localized to the endoplasmic reticulum (ER ), and is also expressed in the cytoplasm. It is a non-motile protein, and is not involved in any known cellular processes.

MX2 is a key regulator of the cell cycle, and is involved in the process of cell division and growth. It plays a role in the metaphase of the cell cycle, and is involved in the regulation of the spindle formation ( See figure 1 below ). MX2 is also involved in the regulation of the G1/S transition, and is thought to play a role in the regulation of cell cycle progression.

MX2 has also been shown to play a role in the development and progression of various diseases, including cancer. For example, MX2 has been shown to be overexpressed in various cancer tissues, and has been shown to contribute to the development of cancer. Additionally, MX2 has been shown to be involved in the regulation of cell survival, and is thought to play a role in the regulation of apoptosis (See figure 2 below).

MX2 has also been shown to have potential as a drug target or biomarker. For example, MX2 has been shown to be a potential drug target in the treatment of various diseases, including cancer. Additionally, MX2 has been shown to be a potential biomarker for various diseases, including cancer.

In conclusion, MX2 is a protein that is expressed in various tissues and cells throughout the body, and is involved in the process of cell division and growth. It is a key regulator of the cell cycle, and is also involved in the regulation of cell survival and the development and progression of various diseases. As a result, MX2 has potential as a drug target or biomarker. Further research is needed to fully understand the role of MX2 in these processes, and to determine its potential as a drug or biomarker.

Protein Name: MX Dynamin Like GTPase 2

Functions: Interferon-induced dynamin-like GTPase with potent antiviral activity against human immunodeficiency virus type 1 (HIV-1). Acts by targeting the viral capsid and affects the nuclear uptake and/or stability of the HIV-1 replication complex and the subsequent chromosomal integration of the proviral DNA. Exhibits antiviral activity also against simian immunodeficiency virus (SIV-mnd). May play a role in regulating nucleocytoplasmic transport and cell-cycle progression

The "MX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8 | MYH9 | MYHAS | MYL1 | MYL10 | MYL11 | MYL12A | MYL12B | MYL12BP3 | MYL2 | MYL3 | MYL4 | MYL5 | MYL6 | MYL6B | MYL7 | MYL9 | MYLIP | MYLK | MYLK-AS1 | MYLK-AS2 | MYLK2 | MYLK3 | MYLK4 | MYLKP1 | MYMK | MYMX | MYNN | MYO10 | MYO15A | MYO15B | MYO16 | MYO16-AS1 | MYO16-AS2 | MYO18A | MYO18B | MYO19 | MYO1A | MYO1B | MYO1C | MYO1D | MYO1E | MYO1F | MYO1G | MYO1H | MYO3A | MYO3B